ArticleFrontiers in immunology2023

A novel interleukin-2-based fusion molecule, HCW9302, differentially promotes regulatory T cell expansion to treat atherosclerosis in mice.

Xiaoyun Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.